Clinically Validated Digital Therapeutics Summit 2018

Clinically Validated Digital Therapeutics Summit is organized by Hanson Wade and will be held from Dec 03 - 04, 2018 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Course Description:
Digital Therapeutics are storming into the healthcare mainstream, offering a novel and effective way of preventing and treating some of the world's most medically unmet and chronic disease conditions.

The inaugural Clinically Validated Digital Therapeutics Summit 2018 is a dedicated scientific and networking forum for pharmaceutical, biotech and healthcare pioneers to capitalize on this emerging therapeutic class.

With a multitude of lifestyle and wellness applications claiming patient benefit, the Clinically Validated Digital Therapeutics 2018 has been built with pharmaceutical and healthtech insight to tackle four key obstacles to successfully building and commercializing robustly validated digital therapeutics:

• Design, develop and clinically validate
• Secure regulatory approval
• Demonstrate and drive fair valuation for reimbursement
• Assimilate into healthcare practice

Attend the Clinically Validated Digital Therapeutics Summit 2018 to hear from pharma digital leaders, DTx pioneers and healthcare innovators as they guide you, step-by-step, through the process of developing and delivering robustly validated digital therapeutics to market.

Time:
8:00 am to 5:00 pm

Speakers:
Joris Van Dam (Novartis), Alex Waldron (Pear Therapeutics), Megan Coder (Digital Therapeutics Alliance), David Benshoof Klein (Click Therapeutics), Ainslie Hatch (Otsuka), Dirk Schapeler (Bayer), Melinda Decker (AstraZeneca), Eddie Martucci (Akili Interactive), Kai Gait (GSK)

Additional details will be posted as soon as they are available.